Literature DB >> 8815804

Inherited diseases of the vasculature.

C L Shovlin1, J Scott.   

Abstract

This review focuses on a spectrum of inherited disorders in which recent genetic advances have made a significant contribution to our understanding of vascular pathology and homeostasis. They are discussed according to the type of blood vessel affected and the compounded physiological processes that include angiogenesis, vascular development, and defects in the structure and regulation of the mature vessel. Vascular malformations, arterial aneurysms and dissection, telangiectasia, infiltrative vascular disease, and inherited tumors and disorders of neovascularization are discussed in a variety of settings. Disease roles for endoglin, tissue inhibitor of metalloproteinases 3 (TIMP3), and vascular endothelial growth factor (VEGF) dysregulation are highlighted (175 references).

Entities:  

Mesh:

Year:  1996        PMID: 8815804     DOI: 10.1146/annurev.ph.58.030196.002411

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


  5 in total

1.  Integrin α7 binds tissue inhibitor of metalloproteinase 3 to suppress growth of prostate cancer cells.

Authors:  Lang-Zhu Tan; Yang Song; Joel Nelson; Yan P Yu; Jian-Hua Luo
Journal:  Am J Pathol       Date:  2013-07-02       Impact factor: 4.307

2.  Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia.

Authors:  C L Shovlin; J M Hughes; J Scott; C E Seidman; J G Seidman
Journal:  Am J Hum Genet       Date:  1997-07       Impact factor: 11.025

Review 3.  Role of crosstalk between phosphatidylinositol 3-kinase and extracellular signal-regulated kinase/mitogen-activated protein kinase pathways in artery-vein specification.

Authors:  Charles C Hong; Tsutomu Kume; Randall T Peterson
Journal:  Circ Res       Date:  2008-09-12       Impact factor: 17.367

4.  Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells.

Authors:  Satoshi Hirakawa; Young-Kwon Hong; Natasha Harvey; Vivien Schacht; Kant Matsuda; Towia Libermann; Michael Detmar
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

5.  MAb NJ001 inhibits lung adenocarcinoma invasiveness by directly regulating TIMP-3 promoter activity via FOXP1 binding sites.

Authors:  Chunrong Gu; Ying Luo; Shichang Zhang; Jian Xu; Jiexin Zhang; Huanyu Ju; Jingping Liu; Lixia Zhang; Yan Zhang; Lei Wu; Erfu Xie; Ting Xu; Shiyang Pan
Journal:  Thorac Cancer       Date:  2020-08-03       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.